Q HOLDINGS, INC. EMPLOYMENT & PROPRIETARY RIGHTS AGREEMENTProprietary Rights Agreement • October 18th, 2011 • Grace 2, Inc. • Blank checks • Utah
THIS AGREEMENT is made and entered into by and between Q Holdings, Inc. (the “Company”), and Steven J. Borst (the “Employee”), and will become effective on October 13, 2011. Employee also has entered into an employment agreement with Q Therapeutics, Inc., (“Q Therapeutics Agreement”) and if there are any inconsistencies or omissions between this Agreement and the Q Therapeutics Agreement, the terms of the Q Therapeutics agreement shall prevail.
REDACTED EXCLUSIVE LICENSE AGREEMENT dated October 5, 2005 between Q Therapeutics, Inc. and UNIVERSITY OF UTAH RESEARCH FOUNDATIONExclusive License Agreement • October 18th, 2011 • Grace 2, Inc. • Blank checks • Utah
THIS EXCLUSIVE LICENSE AGREEMENT (“AGREEMENT”) is entered into this ______ day of October, 2005 by and between the UNIVERSITY OF UTAH RESEARCH FOUNDATION, a Utah nonprofit corporation, having its principal place of business at 615 Arapeen Drive, Suite 310, Salt Lake City, UT 84108, hereinafter referred to as “LICENSOR,” and Q Therapeutics, Inc., a Delaware corporation having its principal place of business at 615 Arapeen Drive, Suite 102, Salt Lake City, UT 84108, hereinafter referred to as “LICENSEE.” This AGREEMENT replaces and consolidates a previous set of three license agreements entered into the 9th day of August, 2002 by and between LICENSOR and LICENSEE (then formerly known as Cue Therapeutics), identified by LICENSOR as Exclusive License #0837 for APCs, Exclusive License #0838 for GRPs, NCSCs and NEPs, and Non-Exclusive License #0840 for NEPs.
AGREEMENT AND PLAN OF MERGER BY AND AMONG GRACE 2, INC., Q ACQUISITION, INC., AND Q THERAPEUTICS, INC. OCTOBER 13, 2011Agreement and Plan of Merger • October 18th, 2011 • Grace 2, Inc. • Blank checks • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") is made and entered into as of October 13, 2011, by and among GRACE 2, INC., a Delaware corporation ("PubCo"), Q ACQUISITION, INC., a Delaware corporation and a wholly-owned subsidiary of PubCo (the "Merger Sub"), and Q THERAPEUTICS, INC., a Delaware corporation (the “Company”). PubCo, Merger Sub, and the Company each, individually, a "Party" or, collectively, the "Parties."
